Below are how our 12 portfolios performed w/e Sept. 6th, in descending order, with links to my articles this week on each portfolio where available: American Cannabis MSO Stocks Portfolio; UP 3.6% Conservative "Cannabis" Stocks Portfolio: UP 2.6% Cloud Computing SaaS Stocks Portfolio: DOWN 3.1% (Source) AI Mega-Cap Stocks Portfolio:...
Psychedelic Compound Drug Stocks Portfolio DOWN w/e Sept. 6th
An Introduction While the psychedelic compound-based drug market is expected to triple over the next few years which should create many winning stocks in the years to come, the stocks of the companies involved are having growing pains. Some Background Shares of clinical-stage companies developing treatments based on psychedelic compound-based...
Psychedelic Compound Drug Stocks DOWN 16% In August – Here’s Why
An Introduction The psychedelic compound-based drug market is expected to triple over the next few years which should create many winning stocks in the years to come. By Lorimer Wilson Some Background Shares of clinical-stage companies developing treatments based on psychedelic compound-based drugs moved lower in early August after the...